Q3 2019 Photocure ASA Earnings Call Transcript
All right. Well, good morning, everyone. Welcome to Photocure ASA's results for third quarter and first 9 months of 2019. I am Dan Schneider, CEO and President of Photocure. With me today is Erik Dahl, CFO. Usual disclaimers are in effect for today's presentation.
So let's start with our strategy. It's been an exciting quarter, a lot has happened and a lot will continue to happen. But the strategy is always good to go back to, so you get a road map for where Photocure is going.
This is a 4-step process for us. Step one, the acceleration phase, which is where we are today and why you're sitting in your seats today, and that is how are we progressing with Cysview and Hexvix, driving the breadth and the depth in the accounts across the U.S., Nordics and Europe.
The next step is expanding and expanding could come in many different ways; it's geographies, it's indications, it's product improvements, it's commercial initiatives, all these things intended to expand the use of Cysview and Hexvix in the marketplace.
If we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |